Agilent Technologies has an average rating of overweight and mean price target of $181.89, according to analysts polled by FactSet.

Proscia, a Philadelphia-based digital pathology software company serving more than 4,000 laboratories, hospitals and clinics, ...

Agilent just set a fresh 52-week high at $177.75, 1.25% above the peak it made less than a week ago. The life sciences tools ...

Shares of Keysight Technologies Inc. slid 8.74% to $311.52 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.02% ...

When proceeding with product development or improvement, organizing 'what you want to investigate' and 'what analysis methods ...

Singapore Exchange Group CEO Loh Boon Chye has begun succession planning ahead of his current contract's expiry in mid-July 2027, telling the exchange's chairman that they should do ...

Global Toxicology Drug Screening Market was valued at USD 15.94 Bn in 2025 and is expected to grow at 8.42% CAGR to reach USD ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Proteoforms are the primary effectors of biological function, and uniting the various technologies, applications, and institutions in one organization will greatly increase our knowledge and ...

John Crowley, president and CEO of the Washington, DC-based Biotechnology Innovation Organization, warned that overly broad investment restrictions could create uncertainty for innovators and ...

Dublin, Oct. (GLOBE NEWSWIRE) -- "Bioconjugation Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global bioconjugation market is experiencing rapid growth, supported by ...

More Bonds of Agilent Technologies Inc. Moody’s Daily Credit Risk Score About the Agilent Technologies Inc.-Bond (US00846UAQ40) The Agilent Technologies Inc.-Bond has a maturity date of 9/9/2027 and ...